Avicanna Inc. (AVCN:CA) Discusses Strategic Pivot, Business Pillars, and Pharmaceutical Pipeline Progress Transcript

Core Insights - Avicanna Inc. has experienced a progressive year and is focused on providing a corporate update on its developments and future plans [1] Company Overview - Avicanna was founded in 2016 as a pharmaceutical drug development and delivery company located in Toronto's MaRS Discovery District, initially part of a Johnson & Johnson incubator [2] - The company spent its early years concentrating on pharmaceutical development, focusing on proprietary drug delivery systems and patentable technologies for clinical development [3] - In 2021, Avicanna strategically pivoted to take some of its formulations and products into new markets [3]